| dc.contributor.author | Galley, Helen | |
| dc.contributor.author | Allen, L. | |
| dc.contributor.author | Collin, P.J. | |
| dc.contributor.author | Galt , SP | |
| dc.contributor.author | Webster, Nigel Robert | |
| dc.date.accessioned | 2022-09-27T23:07:51Z | |
| dc.date.available | 2022-09-27T23:07:51Z | |
| dc.date.issued | 2022-11-01 | |
| dc.identifier | 218856519 | |
| dc.identifier | 1d8ce188-105a-41fa-98c1-5d57917958ea | |
| dc.identifier | 36046952 | |
| dc.identifier | 000853119000001 | |
| dc.identifier | 85137828111 | |
| dc.identifier.citation | Galley , H , Allen , L , Collin , P J , Galt , SP & Webster , N R 2022 , ' Dose assessment of melatonin in sepsis (DAMSEL2) study : Pharmacokinetics of two doses of oral melatonin in patients with sepsis ' , Journal of Pineal Research , vol. 73 , no. 4 , 12830 . https://doi.org/10.1111/jpi.12830 | en |
| dc.identifier.issn | 0742-3098 | |
| dc.identifier.uri | http://aura-test.abdn.ac.uk/handle/2164/19162 | |
| dc.description | Open Access via the Wiley OA Agreement Funding The work was funded by the Scottish Government under the Experimental and Translational Medicine funding scheme of the Chief Scientist Office of Scotland, UK, reference number ETM/538 Funding Information: Written informed consent was obtained either from the patient, or, since most of the patients were not able to consent for themselves, their legal representative—a welfare guardian, a welfare attorney, a near relative or close friend, a clinical person not involved in the study, or another independent person nominated by the healthcare provider, according to the Medicines for Human Use (Clinical Trial) Regulations 2004. Trial Steering and Data and Safety Monitoring Committees with external chairs were established. The study was sponsored jointly by the University of Aberdeen and NHS Grampian and was monitored by NHS Grampian. The work was funded by the Chief Scientist Office of Scotland (Reference number ETM/538). Funding Information: The work was funded by the Scottish Government under the Experimental and Translational Medicine funding scheme of the Chief Scientist Office of Scotland, UK, reference number ETM/538. Publisher Copyright: © 2022 The Authors. Journal of Pineal Research published by John Wiley & Sons Ltd. | en |
| dc.format.extent | 12 | |
| dc.format.extent | 1755170 | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Journal of Pineal Research | en |
| dc.subject | melatonin | en |
| dc.subject | sepsis | en |
| dc.subject | pharmacokinetics | en |
| dc.subject | clinical trial | en |
| dc.subject | R Medicine | en |
| dc.subject | Chief Scientist Office (CSO) | en |
| dc.subject | ETM/538 | en |
| dc.subject.lcc | R | en |
| dc.title | Dose assessment of melatonin in sepsis (DAMSEL2) study : Pharmacokinetics of two doses of oral melatonin in patients with sepsis | en |
| dc.type | Journal article | en |
| dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
| dc.contributor.institution | University of Aberdeen.Medical Education | en |
| dc.description.status | Peer reviewed | en |
| dc.identifier.doi | https://doi.org/10.1111/jpi.12830 | |
| dc.identifier.vol | 73 | en |
| dc.identifier.iss | 4 | en |
